🇺🇸 FDA
Pipeline program

HEC113995

HEC113995-P-04/CRC-C2006

Phase 1 small_molecule completed

Quick answer

HEC113995 for Major Depressive Disorder is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Major Depressive Disorder
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials